Visit
VJSocial
#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:
👉http://ow.ly/70he50KOSG1👈
#MPNsm #HemOnc #BloodCancerAwarenessMonth
First session tomorrow! (How time flies…..) https://twitter.com/lymphoma_soph/status/1573994220594941957
Are you a registrar looking to learn the evidence base for the diagnosis & management of #lymphoma? Or a consultant/nurse looking for an update to your knowledge around research & practice? #LymphomaManagement Course is for you! > http://lymphoma-action.org.uk/LymphomaManagement @graham74GC @tobyeyre82
We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:
🎥: http://ow.ly/ibfm50KOSf3
@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth
We're pleased to bring you another podcast! 🤩
Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.
🎧: http://ow.ly/2Top50KQC0l
#MMsm #HemOnc #ImmunoOnc
VJSocial
At this year's EHA meeting, we spoke with leading experts about what was trending on Twitter and how you can make the most out of Twitter in your professional role.
Learn how to make the most out of Twitter in your professional role and stay up to date with what's trending at EHA 2021.
During this year's EHA meeting, VJSocial will be hosting a series of social media masterclasses to discuss trending topics across the spectrum of hematological malignancies and help hematologists, researchers, nurses, and allied medical professionals learn how to leverage the power of Twitter in their professional roles.
#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:
👉http://ow.ly/70he50KOSG1👈
#MPNsm #HemOnc #BloodCancerAwarenessMonth
First session tomorrow! (How time flies…..) https://twitter.com/lymphoma_soph/status/1573994220594941957
Are you a registrar looking to learn the evidence base for the diagnosis & management of #lymphoma? Or a consultant/nurse looking for an update to your knowledge around research & practice? #LymphomaManagement Course is for you! > http://lymphoma-action.org.uk/LymphomaManagement @graham74GC @tobyeyre82
We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:
🎥: http://ow.ly/ibfm50KOSf3
@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth
We're pleased to bring you another podcast! 🤩
Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.
🎧: http://ow.ly/2Top50KQC0l
#MMsm #HemOnc #ImmunoOnc
VJHemOnc is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
